The Food and Drug Administration (FDA) has approved a domestically-developed and produced antibody reagent for the COVID-19 coronavirus disease, the first of its kind licensed in Taiwan, an FDA official said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwanese shuttler Lin Chun-yi finishes 2nd at Orléans Masters
03/10/2025 10:49 AM - Society
High of 30°C forecast for parts of Taiwan Monday
03/10/2025 10:19 AM - Business
U.S. dollar up in Taipei trading
03/10/2025 10:11 AM - Society
Taiwan headline news
03/10/2025 10:09 AM - Business
Taiwan shares open lower
03/10/2025 09:11 AM